Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 25 member 35 (SLC25A35) is a mitochondrial carrier protein belonging to the SLC25 family, which functions as a transporter of metabolites across the inner mitochondrial membrane[3][5]. Like other SLC25 family members, it is thought to play important roles in mitochondrial metabolite exchange, energy production, and cellular metabolism[2][3]. SLC25A35 is a protein-coding gene expressed in various tissues, but its specific substrate(s) and transport mechanism remain poorly characterized compared to other family members. Alterations in SLC25A35 have been linked to dilated cardiomyopathy, suggesting a role in cardiac metabolic health[5]. No drugs or specific targeting mechanisms are currently known for SLC25A35, and there are no established biomarkers or safety concerns directly attributed to its inhibition or modulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 35 (SLC25A35).